Implanon sub-dermal implant: an emerging method of contraception in Ilorin, Nigeria

被引:21
作者
Balogun, O. R. [1 ,2 ]
Olaomo, N. [2 ]
Adeniran, A. S. [1 ,2 ]
Fawole, A. A. [1 ,2 ]
机构
[1] Univ Ilorin, Dept Obstet & Gynaecol, Ilorin, Nigeria
[2] Univ Ilorin, Teaching Hosp, Dept Obstet & Gynaecol, Ilorin, Nigeria
来源
JOURNAL OF MEDICAL AND BIOMEDICAL SCIENCE | 2014年 / 3卷 / 01期
关键词
Implanon; implant; sub-dermal; contraceptive; Ilorin; Nigeria;
D O I
10.4314/jmbs.v3i1.1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Implanon, a single rod sub-dermal implant is a relatively new contraceptive which offers long term reversible contraception for women. This study seeks to determine the safety, efficacy and acceptor characteristics of Implanon at the family planning clinic of University of Ilorin Teaching Hospital (UITH), Ilorin, Nigeria. This study involves a retrospective review of 88 clients who used Implanon from January 2007 to December 2011 at the family planning clinic of the UITH, Ilorin. Of the 2,456 clients who had contraception during the period, 88 had Implanon giving a 3.6% uptake. The mean age of Implanon users in the study was 33.4 years, no teenager used the method and 72(81.8%) knew about the method from clinic staff. Women with two living children constituted 29(33%) of the total users, 78(88.6%) users had at least secondary education, all except one client were married and religion did not influence its use. Twenty two (25%) users had side effects, the commonest being menstrual irregularity in 13(59%) of the participants. Discontinuation rate was 26.1% and the commonest reason for discontinuation was the desire to get pregnant 8(35%). The Pearl Index for Implanon in the study was 0. Implanon is an effective long term hormonal contraceptive appropriate in a wide range of women with tolerable side effect profile but is currently underutilised. Wider publicity, education and access are needed to improve client uptake..
引用
收藏
页码:1 / 5
页数:5
相关论文
共 18 条
[1]   RETRACTED: A pilot efficacy study with a single-rod contraceptive implant (Implanon®) in 200 Indonesian women treated for ≤4 years (Retracted Article) [J].
Affandi, B ;
Korver, T ;
Geurts, TBP ;
Bennink, HJTC .
CONTRACEPTION, 1999, 59 (03) :167-174
[2]  
Aisien AO, 2010, NIGER J CLIN PRACT, V13, P331
[3]  
Association of Reproductive Health Professionals, 2008, HIST SUBD CONTR IMPL
[4]  
Burkman R. T., 2007, CURRENT DIAGNOSIS TR
[5]  
Clerk N. T., 2006, TXB OBSTET GYNAECOLO
[6]   Safety and efficacy of Implanon™, a single-rod implantable contraceptive containing etonogestrel [J].
Funk, S ;
Miller, MM ;
Mishell, DR ;
Archer, DF ;
Poindexter, A ;
Schmidt, J ;
Zampaglione, E .
CONTRACEPTION, 2005, 71 (05) :319-326
[7]  
Ladipo O A, 2005, Afr J Reprod Health, V9, P16
[8]   Continuation rates of Implanon® in the UK:: data from an observational study in a clinical setting [J].
Lakha, Fatim ;
Glasier, Anna F. .
CONTRACEPTION, 2006, 74 (04) :287-289
[9]   RETRACTED: Insertion and removal of Implanon® (Retracted Article) [J].
Mascarenhas, L .
CONTRACEPTION, 1998, 58 (06) :79S-83S
[10]   Determinants of low family planning use and high unmet need in Butajira District, South Central Ethiopia [J].
Mekonnen, Wubegzier ;
Worku, Alemayehu .
REPRODUCTIVE HEALTH, 2011, 8